Introduction
Many reports have implicated cell surface sialic acid moieties in the regulation of the immune response, as mediators of disorders, and in alteration of the metastatic potential of tumorigenic cells (for examples, see Dennis and Laferte, 1987; Piller et al., 1991; Pilatte et al., 1993; Takada et al., 1993; Umansky et al., 1996; Thomas, 1996) . Of particular significance is that the B cellrestricted molecule, CD22, has a carbohydrate-binding domain that specifically recognizes α2,6-linked sialic acid residues Keppler et al., 1992; Munro et al., 1992; Powell and Varki, 1994) . During B-cell activation, CD22 associates with the BCR complex that includes protein tyrosine phosphatase 1C, Syk, and phospholipase C-γ1 via their Src-homology 2 (SH2) domains. Together, the BCR complex triggers elevation of intracellular Ca 2+ and subsequent downstream signaling events (Lankester et al., 1995; Law et al., 1996) ; for review see (Law et al., 1994) . It is proposed that interaction of CD22 with α2,6-sialic acid ligands is a modulatory mechanism for B-cell activation and proliferation (Stamenkovic et al., 1991; Aruffo et al., 1992; Schulte et al., 1992; Tuscano et al., 1996; Cyster and Goodnow, 1997) . Recognition of CD22 to α2,6-linked sialyl ligands may also participate in adhesion of B-cells to activated endothelial cells (Hanasaki et al., 1994; Hanasaki et al., 1995) . B-Cell maturation is also accompanied by appearance of cell-surface α2,6-sialic acids (Erikstein et al., 1992) and induction of the cognate sialyltransferase, ST6Gal I (β-galactoside α2,6-sialyltransferase, SiaT-1, ST6N, EC# 2.6.99.1). Mice unable to express ST6Gal I exhibit severely compromised B-cell proliferative response, retarded T-cell dependent and T-cell independent activation, and dramatically depressed IgM (Hennet et al., 1998) .
While SIAT1, the gene encoding the human ST6Gal I, is expressed in most tissues, its level of expression varies dramatically from tissue to tissue Kitagawa and Paulson, 1994) . Differential SIAT1 expression among tissues is due largely to the existence of multiple promoters (Wang et al., 1990 (Wang et al., , 1993 . Transcription from the different promoter regions results in a family of mRNAs sharing the same protein coding domains and differing among each other only at their 5′-untranslated regions. In human, at least three physically distinct promoter regions exist (see Figure 1 ). Promoter P1 controls expression in liver, the tissue with typically the highest ST6Gal I levels (Wang et al., 1993; Kitagawa and Paulson, 1994) . P1 activity is modulated by liver-enriched transcription factors HNF-1, DBP, and LAP (Svensson et al., 1992) as well as by glucocorticoids (Wang et al., 1989) . Hepatic SIAT1 expression is part of the acute phase reaction, a hepatic response to acute systemic injury (Kaplan et al., 1983) . P2 promoter activity generates Form 2 mRNA, and contributes to ST6Gal I expression in mature B-cells (Lo and Lau, 1996) . At least one other promoter, P3 (generating Form 3 mRNA), is believed to exist to account for expression in pre-B cells and in other cell types in which neither P1 nor P2 is active.
To understand the regulatory pathways controlling appropriate SIAT1 expression in maturing B-cells and other cell types, we have previously mapped the transcription initiation sites for Form 1 and Form 2 mRNAs (Lo and Lau, 1996) . We demonstrated Fig. 1 . Schematic of ST6Gal I mRNA isoforms. The exon organization of the human ST6Gal I gene, SIAT1, is shown. Shaded regions represent protein coding domains; unshaded regions represent transcribed but untranslated regions. P1, P2, and P3 are transcriptional regulatory regions for the three known SIAT1 mRNA isoforms, Form 1, Form 2, and Form 3, respectively. For example, transcription initiation from P2 yields an mRNA containing Exons X, I, II, III, etc., whereas transcription initiation from P1 yields an mRNA containing only Exons I, II, III, etc. appropriate cellular specificity in the transient expression of reporter genes under the control of SIAT1 sequences flanking these initiation sites. Here, we have extended this study by demonstrating that multiple regulatory elements reside in both the 5′-flanking sequence and in the divergent first transcribed exon unique to Form 2 mRNA, Exon X. Together, these elements confer high level expression in Louckes (a lymphoblastoid cell line of the mature B phenotype), while repressing expression in Reh (a T-null/B-null precursor cell phenotype), and HepG2 (a cell line with hepatic origins). Appropriate regulated expression of a reporter gene requires only a 495 bp SIAT1 P2 segment, comprised of 370 bp of 5′-flanking sequence and the initial 125 bp of the first transcribed exon of Form 2 SIAT1 mRNA.
Results

Specificity of the SIAT1 P2 promoter in transient transfections
The three known isoforms of human SIAT1 mRNA, Form 1, Form 2, and Form 3 are diagrammatically represented in Figure  1 . These isoforms, differing only in their 5′-untranslated regions, are transcriptionally initiated from three physically distinct regulatory regions, P1, P2, and P3, respectively. We have previously mapped the transcription initiation of Form 2 SIAT1 mRNA such that sequence from a unique 150 bp exon region, Exon X, resides immediately 5′ of sequence encoded by Exon I that is shared among all known SIAT1 mRNA forms (Wang et al., 1993) . A CAT reporter gene was placed under the control of a P2 segment containing 784 bp of 5′-flanking sequence and the initial 125 bp (out of a total of 150 bp) of Exon X sequence. This construct, pCAT-P2( -784) was tested by transient transfection into three human cell lines; Louckes, a lymphoblastoid line with mature B phenotype, Reh, a T-null / B-null precursor-cell type, and HepG2, a hepatoma cell line. As shown in Figure 2 , pCAT-P2( -784) was efficiently expressed in Louckes, but only minimally in HepG2 and Reh cells. pSRαCAT, containing CAT under the control of the SV40 early promoter in the presence of SV40 enhancer and human T-cell leukemia virus type-1 long terminal repeat sequence (Takebe et al., 1995) , was used as reference. As also shown in Figure 2 , Louckes and HepG2 express CAT efficiently from this reference plasmid. Expression level is lower in Reh, but higher than that from pCAT-P2( -784).
Contribution of the 5′-flanking region to transcriptional regulation
The genomic segment 5′-adjacent to the transcription initiation point contains regions with consensus to the TATA box (position -29), two potential NF-κB/Rel binding sites (position -703 and -296), and an AP2 site (position -357). To examine further the contribution of this 5′-flanking region to P2 activity, a series of CAT expression vectors that are identical except for the progressive truncation of the 5′-P2 sequence were constructed. As indicated in Figure 2, 
Transcribed Exon X region is sufficient for expression in Louckes but not Reh or HepG2
pCAT-P2( -36), containing only 36 bp of 5′ flanking information, was further manipulated to remove the remaining 5′-flanking region, the putative transcription initiation site, and the first 32 bp of transcribed Exon X sequence. The resulting construct, pCAT-P2( + 32), contains only the + 32 to + 125 region of Exon X ( Figure 3 ). It was expected that deletion of the start site would render pCAT-P2( + 32) transcriptionally silent. Surprisingly, CAT expression in Louckes cells from pCAT-P2( + 32) was slightly elevated compared to pCAT-P2( -36) ( Figure 3 ). Equally important, CAT expression from pCAT-P2( + 32) remained undetectable in Reh and HepG2. Sequence analysis of this Exon X segment against the transcription factor database indicates only two consensus to known cis-acting regulatory elements, LyF-1 (position + 79 to + 87), and GATA-2 (position + 111 to + 120). No consensus TATA box or putative initiator elements are evident.
To examine the molecular basis for pCAT-P2( + 32) activity in Louckes, the + 32 to + 125 segment was cloned in the reverse orientation ( Figure 4A ). The resultant construct, pCAT-P2( -X), was inactive upon introduction into Louckes cells ( Figure 4B , lane 2), suggesting that CAT expression regulated by the + 32 to + 125 segment is orientation-dependent. In a parallel construct, a triple polyadenylation signal was inserted 5′ of the Exon X sequence of pCAT-P2( + 32) to generate pZCAT-P2( + 32) ( Figure  4A ). The triple polyadenylation element should halt transcription events originating 5′ of its placement (Maxwell et al., 1989; Schadlow et al., 1992) . As shown in lane 3 of Figure 4B , pZCAT-P2( + 32) was inactive in Louckes cells, suggesting that CAT expression regulated by the + 32 to + 125 segment is due to transcription initiation events 5′ of the Exon X segment. When RNA from pCAT-P2( + 32) transfected Louckes cells were subjected to Northern blot analysis, the predominant CAT mRNA signal migrated slightly faster than the 1.9 kb 18s ribosomal RNA ( Figure 4C ). The CAT RNA signal was DNase-insensitive and therefore not an artifact of probe hybridization to the transfected plasmids (data not shown). The mobility of the CAT mRNA signal on the Northern blot is also consistent with the utilization of fortuitous transcriptional initiation sites within the vector region (Wang et al., 1993) . Shaded balloons represent putative cis-acting elements and TATA box. X represents Exon X. In pSRαCAT, P+E is the SV40 early promoter and enhancer. LTR is the human T-cell leukemia virus type-1 long terminal repeat. The expression plasmids as diagrammed were transiently introduced into Louckes cells, Reh cells, and HepG2 cells. The results are shown in the bar graph with each data set corresponding to the plasmid schematically diagrammed directly to the right. Relative CAT activity is normalized with 100% arbitrarily assigned to the CAT expression in Louckes cells from pCAT-P2( -784). This experiment was performed four times independently. The data as shown are the mean of the four experimental values. Error bar indicates the range of the experimental values. just 5′ of the cloned Exon X segment in CAT expression from pZCAT-P2( + 32). The transcribed CAT gene, together with the additional 93 bp of Exon X sequence, is predicted to be ∼1.7 kb.
The inability of the + 32 to + 125 Exon X segment, when cloned in the reverse orientation, to mediate CAT expression (see Figure  3B , lane 2) strongly suggests that the segment does not function solely by an enhancer-like mechanism. To examine further the possibility of enhancer-like elements, the + 32 to + 125 segment in both orientations was linked 5′ of the SV40 early promoter. CAT expression by the SV40 promoter was negligible in Louckes cells. Presence of the + 32 to + 125 Exon X segment did not enhance CAT expression by the SV40 promoter (data not shown).
Contribution of sequences 3′ of transcription initiation site to P2 activity
To explore further the role of Exon X, the P2 region is arbitrarily divided into three segments; (1) the genomic region 5′ of position -36; (2) the 68 bp region (position -36 to + 32) containing the TATA box, the transcriptional initiation site, and the first 32 bp of the transcribed Exon X sequence; and (3) the 94 bp Exon X region between + 32 and + 125. Constructs variously deleted of one or two of these segments were transiently introduced into Louckes, Reh, HepG2, and CHO cells ( Figure 5 ). As shown earlier (Figure 2 ), presence of all three segments (pCAT-P2( -370)) enabled efficient CAT expression in Louckes, the mature B-lymphoblastoid cell line. In Reh, the T-null B-null precursor cell line, CAT expression from pCAT-P2( -370) is low but clearly at a detectable level. Expression in the hepatoma line HepG2, as with all constructs using P2 regulatory sequences, is negligible. Removal of the + 32-+ 125 Exon X segment generates pCAT-P2( -415dX), a construct that is 3-fold less active in Louckes cells than pCAT-P2( -370), suggesting the loss of cis-elements enabling efficient expression in Louckes. Quite importantly, pCAT-P2( -415dX) is 3-fold more active in Reh cells than pCAT-P2( -370). Interestingly, the presence or absence of the + 32-+ 125 segment only slightly affects P2 regulated expression of CAT in CHO cells.
In the absence of both the -36 to + 32 segment and the + 32 to + 125 segment [pCAT-P2( -415dTA/X)], P2-mediated CAT expression was below detectable levels in all cell lines examined, including CHO cells. This demonstrates that the 5′-flanking region from position -415 to -36 alone is insufficient for regulated expression of a heterologous gene. As expected from data shown earlier (Figure 2) , pCAT-P2( -36), specifically deleted of the 5′-flanking segment but containing the TATA/transcription start segment and the Exon X segment, is utilized in Louckes cells albeit at a substantially reduced level. Cellular specificity, however, is retained, as evident by barely detectable levels of expression in Reh and HepG2 cells. Expression in CHO cells is not substantially altered by the deletion of the P2 5′-flanking segment.
It is clear that the -36 to + 32 region of P2 contains the minimal information necessary for transcription. In CHO cells, CAT expression from pCAT-P2( -36dX) was clearly detectable and only reduced by 50% compared to other constructs that contain either of the 5′-flanking sequence and the + 32-+ 125 Exon X segment or both. Nevertheless, CAT expression from pCAT-P2( -36dX) was negligible in Louckes, Reh, and HepG2 cells.
Together, the above data indicate that the + 32-+ 125 Exon X region is necessary not only for high level expression in Louckes cells, but also contributes to cellular specificity of expression. Because this region is also the transcribed leader sequence of the Form 2 mRNA, there is the possibility that some of the observed properties may be due to posttranscriptional mechanisms. To address this issue, CAT expression in Louckes cells and Reh cells was monitored on both RNA and protein levels by Northern analyses and CAT assays, respectively. As shown in Figure 6 , relative protein levels and RNA levels were normalized with 100% arbitrarily assigned to the corresponding levels in Louckes cells from pCAT-P2( -370). In general, the measured CAT activity and the RNA level from the expression of the various constructs were in close agreement. The exception was in the expression of pCAT-P2( -415dX), the construct specifically deleted of the of the + 32-+ 125 Exon X segment. Transfection of pCAT-P2( -415dX) into both Louckes and Reh cells resulted in negligible RNA accumulation but substantially higher CAT activities. This observation is consistent with the possibility that the absence of the + 32-+ 125 Exon X segment in the mRNA results in the improved translation efficiency.
Discussion
Past work on the mechanism of SIAT1 expression has been focused on liver where SIAT1 transcription is regulated by P1 (Wang et al., 1990; Svensson et al., 1992) . The P1 promoter is utilized only in cells of hepatic and intestinal epithelial origins (Wang et al., 1990a,b; Vertino-Bell et al., 1994) . Little is known about P2, the promoter utilized for the stage-specific induction of ST6Gal I and the consequent display of cell surface α2,6-linked sialic acids on maturing B-lymphocytes. Our data indicate that a 68bp segment containing the TATA box/transcriptional start site (as in pCAT-P2(-36dX)) is sufficient as a minimal promoter. however sequences necessary for lymphocyte lineage-specific expression reside 5′ and 3′ of this core 68 bp segment.
Either the 5′ or 3′ segment alone can confer expression in B-lineage cells, but not in the hepatic line HepG2. However, the highest level of expression in Louckes, a cell with the mature B-cell phenotype, can be achieved only with the presence of both 5′ and 3′ segments. . Differential contribution of the 5′-flanking and Exon X segments in P2 promoter specificity. The P2 promoter region is divided into three segments: the 5′-flanking region, the -36 to + 32 segment containing the TATA box and transcription start site, and the + 32 to + 125 portion of Exon X. Shown on the left is a schematic of P2-CAT fusion constructs deleting one or two of these three segments. The expression plasmids as diagrammed were transiently introduced into Louckes cells, Reh cells, HepG2 cells, and CHO cells. The results are shown in the bar graph with each data set corresponding to the plasmid schematically diagrammed directly to the right. Each data point is the mean of four independent transfections for CHO cells and two independent transfections for Reh, Louckes, and HepG2 cells. Error bar indicates the range of the experimental values; 100% CAT relative activity is that expressed by pCAT-P2( -784) in Louckes cells (see Figure 2) . Fig. 6 . Contribution of the Exon X segment on the transcriptional and posttranscriptional effects. Shown on the left is a schematic of the P2-CAT fusion constructs deleting one or two of the three segments. Louckes cells and Reh cells were transiently transfected with these CAT-fusion constructs and then analyzed for their CAT expression on RNA and protein levels by Northern analyses and CAT enzyme assays, respectively; 100% CAT expression is assigned to the RNA and protein levels in Louckes cells by pCAT-P2( -370).
The 94 bp region (+32 to +125) of the transcribed 5′-UT region encoded in Exon X was also sufficient for expression in Louckes, albeit at a substantially reduced level from constructs including sequence both 5′ and 3′ of the transcriptional start site. CAT expression under the control of the +32 to +125 P2 segment remained negligible in the precursor cell type, Reh, indicating the presence of element or elements specifying stage-specific expression in this region. The elements residing in the +32 to +125 region are not enhancer-like elements, since they did not exhibit position and orientation independence either alone or in conjunction with an SV40 promoter. At least two transcriptional regulatory properties are conferred by this 94 bp Exon X segment, an activator for expression in mature B-lymphoid cells and a repressor in immature or precursor cells of the lymphocytic lineage. This was evident by deletion of this Exon X segment which resulted in a 3-fold reduction of CAT expression in Louckes cells, but also a 3-fold activation in Reh (see pCAT-P2(-415dX) in Figure 5 ). The +32 to +125 Exon X region has consensus to only two known transcriptional regulatory elements, GATA-2 (position +111 to +120), and LyF-1 (position +79 to +87), both of which are hematopoietic-related elements. GATA-2 is a member of the GATA family of factors with a consensus recognition to (A/T)GATA(A/G) (Merika and Orkin, 1993) . GATA-2 binding sites are found in the promoters and enhancers of globin and non-globin erythroid genes, as well as in the α-and β-globin locus control region. LyF-1 is a general transcriptional regulator binding to the consensus sequence PyPyTGGGAGPu. LyF-1 binding sites are documented in genes whose expression is restricted to lymphocytes (Lo et al., 1991) . Significantly, deletion of this transcribed segment did not relieve the inhibited expression in HepG2, a cell type of hepatic origin.
On the RNA level, suppressed CAT expression in Reh was not alleviated upon removal of either the 5′ or the 3′ segments. This suggests that elements conferring B-developmentally specific expression reside in the 5′-flanking region as well as in the transcribed Exon X segment. Quite interestingly, removal of the Exon X segment (+32 to +125) resulted in enhanced CAT enzymatic expression in both Reh and Louckes without a concomitant elevation in RNA levels. The latter is consistent with an earlier report that the divergent 5′-UT regions of ST6Gal I mRNAs endow different translational efficiencies to the transcripts (Asheim et al., 1993) .
Together, the data suggest that the +32 to +125 segment contributes multiple regulatory properties to the expression of ST6Gal I in B lineage cells. First, in additional to transcriptional regulation, presence of Exon X region may confer altered stability of mRNA in different cell types. Our present data cannot distinguish between altered transcription and mRNA stability as the mechanistic basis of the cellular specificity provided by Exon X. Finally, our data is also consistent with the ability of the Exon X region to alter the efficiency of the mRNA as templates for protein synthesis.
Presence of transcriptional modulatory elements in transcribed sequences is not frequently considered, although examples of this exist in the literature. For example, sequences downstream of the HIV-1 and HIV-2 promoters have been implicated in the control of basal transcription (Emerman et al., 1987) . The cyanobacterial photosensibility gene, psbA, is transcriptionally regulated by a small enhancer region between the cap site and nucleotide +41 (Li and Golden, 1993) . Among eukaryotic genes, silencer type elements are reported to exist within the 5′-UT region of the gene for the neuron-glia cell adhesion molecule (Ng-CAM) (Kallunki et al., 1995) . In the estrogen receptor gene (ER), a 75-bp region in the 5′UT sequence augments expression from the ER promoter (DeConinck et al., 1995) .
Tissue-and cell-specific expression of SIAT1 gene is the result of differential usage of a number of physically distinct promoter regions. Consequently, distinct mRNA isoforms, differing in their 5′-UT domains, are generated. An earlier report implicated these 5′-UT regions in posttranscriptional regulation (Asheim et al., 1993) . Different translational efficiency was observed when the different isoforms were synthesized by in vitro translation, with Form 1 sequence being the most efficiently translated and Form 2 being less efficiently utilized. Here, we provide evidence that the Exon X region that contributes to the 5′-UT sequence of Form 2 mRNA participates in specifying cellular specificity by modulating the level of mRNA. In keeping with the view that multiple and complex pathways of regulation control the expression of SIAT1 in different tissues and cell types, we provide characterization of a promoter region that confers specific regulated expression in mature B cells.
Materials and methods
Construction of plasmids
For progressively 5′-truncated constructs, pSK-del22.5a, containing 784 bp sequence upstream from transcriptional initiation site and 125 bp 5′-untranslated sequence (Exon X) of P2 promoter (Wang et al., 1993) , was used as starting material. This plasmid was first double-digested at contiguous restriction sites ApaI and XhoI followed by the Exonuclease III/mung bean nuclease treatment with various time points to generate serial 5′ deletions. The deleted inserts were then released by single digestion of PstI, separated from their vector by electrophoresis, eluted and re-inserted into upstream of the CAT coding region of pCATenhancer, a promoterless CAT vector (Promega). The positive clones were screened for Exon X and sequence analyzed to determine their precise degree of deletions (see Figure 2 ). For constructs pCAT-P2( + 32), pCAT-P2( -X), pCATCX + , pCATCX -, pCATPX + , and pCATPX -, the plasmid pSK-del22.5a was used as a template to generate a 119 bp PCR-fragment using HL-P48 (5′-AGGAGGAGGTACCTATAGGG-3′) and HL-p49 (5′-GG-ATCCCCCGGGCTGCAG-3′). Each PCR reaction, in a total of 40 µl, is composed of 10 ng of DNA template, 0.5mM of each 2′-deoxynucleoside 5′-triphosphates, 5 U of Taq polymerase, and 0.25 mM of primers under the condition of 93_C 1 min, 42_C 1 min, 72_C 1 min for 30 cycles. The PCR-generated fragment was digested with KpnI and PstI and inserted into the cloning site of pCATKPNenhancer, a modified version of pCATenhancer containing additional KpnI cloning site, to generate pCAT-P2( + 32). The digested PCR-fragment was blunt-end ligated into the cloning site of pCATenhancer, pCATcontrol, and pCATpromoter (Promega) to generate pCAT-P2( -X), pCATCX + /pCATCX -, and pCATPX + /pCATPX -, respectively. The orientation of the inserts in the latter four constructs was sequence determined. For the constructs pCAT-P2( -415dX), and pCAT-P2( -415dTA/X), the plasmid pSK-del22.5a was again used as a template to generate PCR-fragments using two pairs of oligonucleotide primers, HL-p55 (5′-TGTGCCGCCCTGCAGGAACCTCC-3′)/HL-p56 (5′-GACTGGGATCCTTACAACCCTCCCAT-3′), and HL-p54 (5′-GCTTCCTTGACTGCAGCATTTCTTC-3′)/HL-p56, respectively. The PCR-fragments were then blunt-inserted into the cloning site of pCATenhancer. pCAT-P2( -36dX) was generated from pCAT-P2( -415dX) by removing a HindIII fragment from the 5′ region of the insert. pZCAT-P2( + 32) was constructed from the insertion of a triple polyadenylation signal fragment upstream of the insert of pCAT-P2( + 32). The triple polyadenylation signal sequence was released by SalI and BamHI digestion of a plasmid pZluc (Schadlow et al., 1992) , a gift from Dr. Kenneth Gross at Roswell Park Cancer Institute. All constructs were sequenced to verify PCR fidelity. A reference expression construct, pSRαCAT, is a kind gift from Dr. Minoru Fukuda (La Jolla Cancer Research Foundation, La Jolla, CA) (Xu et al., 1995) .
Cell culture and Northern analysis
The human hepatoma cell line HepG2 and the human lymphoblastoid lines Louckes and Reh were obtained and maintained as previously described (Wang et al., 1993) . The Chinese hamster ovary (CHO) cells were grown in minimum essential medium (GIBCO) supplemented with 10% fetal bovine serum, 100 U/ml penicillin, and 100 µl/ml streptomycin. Total cellular RNA was prepared from cells using the guanidine isothiocyanate method (Chirgwin et al., 1979) ; 10 µg of each total RNA was separated on formaldehyde agarose gel (Boedtker, 1971 ) and electrotransferred onto nylon filter (Zetabind, Cuno Inc., Meriden, CT). For probe, a 457 bp insert fragment of pCAT-P2( + 32) was generated by PCR (see Figure 2A ) using oligonucleotide primers HL-p52 (5′-TCATTAATAGATCTGGCACGACAG-3′) and HL-p53 (5′-TTATAGGTGAATTCAGCAACTGACT-3′). The PCR fragment was gel-purified and subjected to PCR amplification in the presence of α 32 P-dATP for five cycles. The blot was then exposed under PhosphorImager screen (Molecular Dynamic, Sunnyvale, CA) overnight and computer quantified.
Transient cell transfection and transfection analysis
Plasmid DNA was prepared over double cesium chloride gradients. Transient transfection of HepG2 cells and CHO cells was performed using the calcium phosphate transfection technique; transient transfection of Louckes cells and Reh cells was accomplished by electroporation as previously described (Wang et al., 1993) . Preparation of cell lysates and subsequent CAT assays were performed within 24-48 h after transfection according to Ausubel et al. (Ausubel et al., 1989) with some modifications. In brief, transfected cells were washed twice with phosphate-buffered saline (PBS), once with TEN (40 mM Tris-Cl, pH 7.5, 1 mM EDTA, pH 8.0, 150 mM NaCl), and resuspended in 100 µl of 0.25 M Tris-Cl, pH 8.0. Cells were sonicated briefly, incubated at 65_C for 10 min, and subjected to freeze-and-thaw once. The lysates were then clarified by quick centrifugation. Protein concentration in each cellular extract was determined by the Bradford reagent (Bio-Rad, Richmond, CA) using bovine serum albumin as a reference standard. Unless stated elsewhere, 20 µg of cell extract were used for each measurement for CAT activity. Each CAT assay, containing 0.25 µCi of [ 14 C]-chloramphenicol (Amersham) and 1 µg of acetyl CoA (Sigma), was assayed at 37_C for 1 h. CAT activity was quantified by thin layer chromatography.
